Ecosystem xbetYandex N.V., an internet and technology company, provides internet search engine in Russia and internationally. In line with internet shopping, delivery services, taxi, etc. Recently company's revenue has started sharp rise.
My personal opinion is that since 2020 yandex has become leading ecosystem in Russia and neighbour countries that speak Russian. It provide better search quality and review algorithm for restaurants than TripAdvisor. Better maps then Google. Good marketplace. Better transl
VTB the russian bank interesting perspectives in the near futureVTB is one of the most important banks in the Russian market and overall one of the pillar of the dynamics of the russian economy
first of quick view of the news :
** hit record retail loans
** earnings are on the rise but monitoring the interest rate is a must for next year forecast
** successful deal of selling the magnit from it's portfolio
second a quick view of the charts
the volumes are steady and the MA 9/MA 50 /MA 200 are forecasting a potential rise of the price of the stock
Idea about MagnitMagnit is a chain of retail stores, the third largest private company in Russia by revenue (after Lukoil and X5 Group). It consists of more than 15 thousand grocery stores, 500 supermarkets, 5 thousand perfume and cosmetics stores, 1 thousand pharmacies, manages a greenhouse complex and its own fleet of 5.7 thousand cars. Founded in 1995. Revenue ₽1553.8 billion (2020). Capitalization ₽600.5 billion
The deal is on the rebound from the support level.
The tool is not fast, it forms an impulse thr
Go drink COMRADE Plan A: Set TP at 319 and chill 260 days.
Plan B: If the price would not consolidate above 275 fastly (within 1W) than sell at 260-275 range.
SL is 176
Idea:
The company has diversified portfolio of low cost vines and champagne. Few soft drinks, heavy alcohol and apple wine.
Cheap price and spread of low-alcohol beverages culture may push stock price
FIXP to go uptrend (FIXprice Group)FixPrice (FIXP) due to tech analysis found a good support at range 598-600.00 as a point of optimal point to start uptrend as an and of ABS to 1st impulse.
FLong
ISKJ | Fundamental Growth +30%0. Top Russian Medical Genetic company
1. Develop alternative to Sputnik COVID-19 vacine named Betuvax-CoV-2
2. Russian Health Ministry approves clinical trails of Betuvax at September 27 2021. Clinical trails involve 116 volonteer without chronic diseases
3. Forecast release date midwinter 2021.
4. In case of anual vaccination of 1% Russian population target price: 120 RUB
5. In case of anu vaccination rate of 4%, target: 320 RUB
6. Govermental support rate up to +10-20% price impact
7. Lot's
OZON. Update.In the last post on OZON, I wrote about the short from the current levels (₽3190) to ₽3000 (support), since the level with this round number is unlikely to be ignored by the market and it should be expected at least a local rebound from it.
After reaching the level of ₽3130, the price bounced, failing to cross the local maximum of ₽3230. The price returned to the level of the limit player, bouncing consistently with less energy. This situation provides for the continuation of the downtrend and
Polymetal(POLY) "Continuation"Disclaimer/
On average, 90% of all stocks move down with the market, and 75% - up.
The wave principle applies to some extent to individual stocks, but counting waves for them is often confusing and has little practical significance. But since the company has a large capitalization, we assume that the state of the shares depends on the psychology of the masses
According to our old plans, we have reached a turning point. Now the 3rd wave is coming.
Gold, contrary to the correction that we
PLong
POLYI am a poor man
sitting on the corner of
Your Conscious
and Your Reality.
All day everyday
I sit in that spot and
beg for change.
But keep your quarters, nickels, dimes
for someone else
'cause all I want is a cup of change.
A cup of change
to water my feeble hope, thorny rose
rooted in concrete hatred.
PLong
NLMK - Deep Value, Inverse H&S, Fat DivsNon stop accumulation, it retraced to the value zone, today's engulfing raising the odds of setting an inverse head and shoulders.
The pink line is an anchored VWAP from the March 2020 low.
Huge dividends.
Aggregate Volume Drift: Pro using 3-minute accumulation data.
OPEC ReportOPEC's monthly report was released yesterday. Analysts of the cartel lowered the estimate of oil demand growth in 2021 to 5.8 million barrels per day (b/d) compared to 5.96 million b/d in the previous forecast. Thus, global demand in 2021 will average 96.6 million b/d.
"The downward revision is mainly due to lower-than-expected actual data for the first three quarters of this year, despite assumptions about good demand for oil in the last quarter of the year, which will be supported by a season
Trad.RU|AAL-RM|LongLong AAL-RM
The system trading idea is activated only when it is fixed in the highlighted blue zone, if the price has gone beyond the highlighted zone, then the transaction is activated 2 minutes after the breakout.
* The author reserves the right to close the deal before reaching the take zone and the stop zone. Closing a deal for subjective reasons does not completely cancel the idea and is not a call to the same action, you can continue developing the idea according to your data, but with
ALong
Trad.RU|HYDR|LongLong HYDR
The system trading idea is activated only when it is fixed in the highlighted blue zone, if the price has gone beyond the highlighted zone, then the transaction is activated 2 minutes after the breakout.
* The author reserves the right to close the deal before reaching the take zone and the stop zone. Closing a deal for subjective reasons does not completely cancel the idea and is not a call to the same action, you can continue developing the idea according to your data, but withou
Descending broadening wedgeQuite high possibility of reversal IMO, not quite sure about power of the upward move
TLong
Pfizer | Fundamental Analysis | Short view Many would agree that a half victory is better than a total defeat. Pfizer and BioNTech have seen this through firsthand experience.
The two partners had hoped that an FDA advisory committee would recommend revaccination with the COVID-19 vaccine to all Americans 16 years of age and older. A week ago, however, the committee voted 16-2 against recommending the Pfizer-BioNTech vaccine for a wide age range.
It wasn't just bad news for these drug companies, however. The FDA advisory committee also
PShort























